Cargando…

Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats

BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information rega...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Jun-Won, Kwon, Euna, Kim, Yun-Soon, Kim, Seung-Hyun, You, Ji-Ran, Kim, Hyoung-Chin, Park, Jin-Sung, Che, Jeong-Hwan, Lee, Sang-Koo, Jang, Ja-June, Kim, Hyeon Hoe, Kang, Byeong-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134578/
https://www.ncbi.nlm.nih.gov/pubmed/30208908
http://dx.doi.org/10.1186/s12906-018-2315-5
_version_ 1783354685410770944
author Yun, Jun-Won
Kwon, Euna
Kim, Yun-Soon
Kim, Seung-Hyun
You, Ji-Ran
Kim, Hyoung-Chin
Park, Jin-Sung
Che, Jeong-Hwan
Lee, Sang-Koo
Jang, Ja-June
Kim, Hyeon Hoe
Kang, Byeong-Cheol
author_facet Yun, Jun-Won
Kwon, Euna
Kim, Yun-Soon
Kim, Seung-Hyun
You, Ji-Ran
Kim, Hyoung-Chin
Park, Jin-Sung
Che, Jeong-Hwan
Lee, Sang-Koo
Jang, Ja-June
Kim, Hyeon Hoe
Kang, Byeong-Cheol
author_sort Yun, Jun-Won
collection PubMed
description BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information regarding TS extract, especially its long-term toxicity, is currently limited. Therefore, the objective of the present study was to evaluate acute and subchronic toxicity of TS extract in rats after oral administration following test guidelines of the Organization for Economic Cooperation and Development (OECD). METHODS: Toxicological properties of TS extract were evaluated by toxicity assays to determine its single-dose acute toxicity (125, 250, 500, 1000, or 2000 mg/kg), 14-day repeated-dose toxicity (125, 250, 500, 1000, or 2000 mg/kg) and 13-week repeated-dose toxicity (31.25, 62.5, 125, 250, and 500 mg/kg) in Sprague-Dawley rats and F344 rats. Hematological, serum biochemical, and histopathological parameters were analyzed to determine its median lethal dose (LD(50)) and no-observed-adverse-effect-level (NOAEL). RESULTS: Oral single dose up to 2000 mg/kg of TS extract resulted in no mortalities or abnormal clinical signs. In 13-week toxicity study, TS extract exhibited no dose-related changes (mortality, body weight, food/water consumption, hematology, clinical biochemistry, organ weight, or histopathology) at dose up to 500 mg/kg, the highest dosage level suggested based on 14-day repeat-dose oral toxicity study. CONCLUSION: Acute oral LD(50) of TS extract in rats was estimated to be greater than 2000 mg/kg. NOAEL of TS extract administered orally was determined to be 500 mg/kg/day in both male and female rats. Results from these acute and subchronic toxicity assessments of TS extract under Good Laboratory Practice regulations indicate that TS extract appears to be safe for human consumption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2315-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6134578
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61345782018-09-13 Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats Yun, Jun-Won Kwon, Euna Kim, Yun-Soon Kim, Seung-Hyun You, Ji-Ran Kim, Hyoung-Chin Park, Jin-Sung Che, Jeong-Hwan Lee, Sang-Koo Jang, Ja-June Kim, Hyeon Hoe Kang, Byeong-Cheol BMC Complement Altern Med Research Article BACKGROUND: Seed of mature Croton tiglium Linne, also known as Tiglium seed (TS), has been widely used as a natural product due to its several health beneficial properties including anti-tumor and antifungal activities. Despite its ethnomedicinal beneficial properties, toxicological information regarding TS extract, especially its long-term toxicity, is currently limited. Therefore, the objective of the present study was to evaluate acute and subchronic toxicity of TS extract in rats after oral administration following test guidelines of the Organization for Economic Cooperation and Development (OECD). METHODS: Toxicological properties of TS extract were evaluated by toxicity assays to determine its single-dose acute toxicity (125, 250, 500, 1000, or 2000 mg/kg), 14-day repeated-dose toxicity (125, 250, 500, 1000, or 2000 mg/kg) and 13-week repeated-dose toxicity (31.25, 62.5, 125, 250, and 500 mg/kg) in Sprague-Dawley rats and F344 rats. Hematological, serum biochemical, and histopathological parameters were analyzed to determine its median lethal dose (LD(50)) and no-observed-adverse-effect-level (NOAEL). RESULTS: Oral single dose up to 2000 mg/kg of TS extract resulted in no mortalities or abnormal clinical signs. In 13-week toxicity study, TS extract exhibited no dose-related changes (mortality, body weight, food/water consumption, hematology, clinical biochemistry, organ weight, or histopathology) at dose up to 500 mg/kg, the highest dosage level suggested based on 14-day repeat-dose oral toxicity study. CONCLUSION: Acute oral LD(50) of TS extract in rats was estimated to be greater than 2000 mg/kg. NOAEL of TS extract administered orally was determined to be 500 mg/kg/day in both male and female rats. Results from these acute and subchronic toxicity assessments of TS extract under Good Laboratory Practice regulations indicate that TS extract appears to be safe for human consumption. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2315-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-12 /pmc/articles/PMC6134578/ /pubmed/30208908 http://dx.doi.org/10.1186/s12906-018-2315-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yun, Jun-Won
Kwon, Euna
Kim, Yun-Soon
Kim, Seung-Hyun
You, Ji-Ran
Kim, Hyoung-Chin
Park, Jin-Sung
Che, Jeong-Hwan
Lee, Sang-Koo
Jang, Ja-June
Kim, Hyeon Hoe
Kang, Byeong-Cheol
Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title_full Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title_fullStr Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title_full_unstemmed Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title_short Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats
title_sort assessment of acute, 14-day, and 13-week repeated oral dose toxicity of tiglium seed extract in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134578/
https://www.ncbi.nlm.nih.gov/pubmed/30208908
http://dx.doi.org/10.1186/s12906-018-2315-5
work_keys_str_mv AT yunjunwon assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kwoneuna assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kimyunsoon assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kimseunghyun assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT youjiran assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kimhyoungchin assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT parkjinsung assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT chejeonghwan assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT leesangkoo assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT jangjajune assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kimhyeonhoe assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats
AT kangbyeongcheol assessmentofacute14dayand13weekrepeatedoraldosetoxicityoftigliumseedextractinrats